AIM ImmunoTech Inc. (AIMI) earnings · rev $170.0K
AIM ImmunoTech Inc. (AIMI) is a biotechnology company listed on US.
This AIMI earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported AIMI revenue for 2024-12-31 was $170.0K. Net income was -$17.3M. Revenue was down 15.8% from 2023-12-31 to 2024-12-31. AIMI currently screens at market cap $878.9K.
When the next AIMI 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 15.8% from 2023-12-31 to 2024-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full AIMI research stays on the stock page; the tape stays on the quote page.
Not investment advice.